Upregulation of Serum and Tissue Vascular Endothelial Growth Factor Correlates With Angiogenesis and Prognosis of Oral Squamous Cell Carcinoma

Journal of Oral and Maxillofacial Surgery

Volumn 65, Issue 1, 2007, Pages 17-21

  Shang, Zheng Jun ^a   Li, Jin Rong ^b   Li, Zu Bing ^b  

^a Wuhan University   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CELL DENSITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MALE; MICROVASCULARIZATION; MOUTH CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; COLORING AGENTS; CYTOPLASM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICROCIRCULATION; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845477915     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2005.11.105     Document Type: Article

References (22)

1. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285 (1971) 1182
2. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4
3. Dvorak H.F., Brier G., Weich H.A., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146 (1995) 1029
4. Kim K.J., Li B., Winer J., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362 (1993) 841
5. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527
6. Carlile J., Harada K., Baillie R., et al. Vascular endothelial growth factor (VEGF) expression in oral tissue: possible relevance to angiogenesis, tumor progression and field cancerisation. J Oral Pathol Med 30 (2001) 449
7. Maeda K., Chung Y.S., Ogawa Y., et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77 (1996) 858
8. Brown L.F., Berse B., Jackman R.W., et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143 (1993) 1255
9. Miyake H., Hara I., Yamanaka K., et al. Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer. Urology 53 (1999) 302
10. Eroglu A., Demirci S., Ayyildiz A., et al. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer. Br J Cancer 80 (1999) 1630
11. Ferrani G., and Scagliotti G.V. Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients. Eur J Cancer 13 (1996) 2386
12. Qian C.N., Zhang C.Q., Guo X., et al. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer 88 (2000) 255
13. Brown L.F., Lanir N., McDonagh J., et al. Fibroblast mitogen in fibrin gel matrices. Am J Pathol 142 (1993) 273
14. Connolly D.T., Heuvelman D.M., Nelson R., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84 (1989) 1470
15. Leung D.W., Cachinaes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenesis mitogen. Science 246 (1989) 1036
16. Senger D.R., Connolly D.T., Van de Water L., et al. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50 (1990) 1774
17. Toi M., Hoshina S., Takayanagi T., et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85 (1994) 1045
18. Liotta L.A., Kleinerman J., and Saidel G.M. The significance of heterogeneous tumor cell clumps in the metastatic progress. Cancer Res 36 (1976) 889
19. Nagy J.A., Brown L.F., Senger D.R., et al. Pathogenesis of tumor stroma generation: A critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948 (1989) 305
20. Papapetropoulos A., Garcia-Cardena G., Madri J.A., et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100 (1997) 3131
21. Ziche M., Morbidelli L., Choudhuri R., et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99 (1997) 2625
22. Morbidelli L., Chang C.H., Douglas J.G., et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270 (1996) 411